Inlyta Tablets 5mg (axitinib) from Pfizer, YJ code 4291027F2025 (5mg 1 tablet), is indicated for the treatment of advanced renal cell carcinoma, either alone after prior systemic therapy or in combination with pembrolizumab for first-line treatment.
Inlyta Tablets 5mg
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).
